Endo Pharmaceuticals recalls

2 official recalls and safety alerts involving Endo Pharmaceuticals since 2023-04, from FDA · Drug. Newest first. Check the official notice for exact models and batch codes.

This list only includes recalls Recall Atlas has collected since 2021-10. A product not listed here may still be affected; check with Endo Pharmaceuticals or the relevant agency.

  1. 2024-08-07
  2. US
    Drugs & medicalClass I

    Endo Pharmaceuticals, Inc. recalls Clonazepam Orally Disintegrating Tablets, USP (C-IV) 0.125mg, 60 tablets per carton (10 blister cards containing 6 tablets each), Rx…

    Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled as 0.125 mg instead of 0.25 mg. The blister strips inside the product carton reflect the correct strength of 0.25 mg.

    FDA · DrugEndo Pharmaceuticals, Inc.Nationwide in the USA and Puerto RicoOfficial notice →
  3. 2023-04-05
  4. US
    Drugs & medicalClass II

    Endo Pharmaceuticals, Inc. recalls Calcitonin Salmon Nasal Spray, USP, 2200 International Units per mL corresponding to 200 International Units/spray, 3.7 mL bottle, Rx…

    Failed Impurities/Degradation Specifications and Subpotent Drug: High Out of Specification results for a known and unknown impurity as well as low Out of Specification results for assay.

    FDA · DrugEndo Pharmaceuticals, Inc.Nationwide in the USA and Puerto RicoOfficial notice →